Cialis
Product Images NDC 43353-044

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Cialis (NDC 43353-044). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 5mg (43353 0044 04)

This is a description of Tadalafil (Cialis). It is a medication available in a pack of 4 tablets with 5mg strength per tablet. The National Drug Code (NDC) for this drug is 43353004404. However, the text contains errors and non-English characters.*

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Chemical Structure (Cialis Uspi F001 Structure V1)

FDA Label Image

Figure (Cialis Uspi F001 V2)

This is a chart that shows the concentration of tadalafil in plasma in micrograms per liter over time in hours, following the administration of different doses. The chart displays the results for a single 20mg tadalafil dose, a single 5mg tadalafil dose, and a once-daily 5mg tadalafil dose following 5 consecutive days of administration. The time points are labeled on the X-axis, and the concentration is labeled on the Y-axis.*

FDA Label Image

Figure (Cialis Uspi F002 V1)

This is a chart that indicates the difference in blood pressure (in millimeters of mercury) between Tadalafil and a Placebo, specifically for Standing Systolic BP and Standing Diastolic BP. The chart also shows the values for Supine Systolic BP and Supine Diastolic BP at different time intervals. No other information is available.*

FDA Label Image

Figure (Cialis Uspi F003 V1)

This appears to be a table or chart with numerical values and medication names. The medication names include "Tadalafil" and "doxazosin", which might indicate a comparison of drug effectiveness. There are also some numerical values, which could be measurements of some sort. Without more context, it is difficult to determine the exact purpose or meaning of this text. Therefore, a useful description cannot be provided.*

FDA Label Image

Figure (Cialis Uspi F004 V1)

FDA Label Image

Figure 5 (Cialis Uspi F005 V1)

This is a graph showing the change from baseline in IPSS total score for a treatment group compared to a placebo group over the course of 12 weeks. There is a significant difference between the two groups indicated by the asterisk and the text "p<0.01". However, without more information about the study or treatment, it is difficult to draw further conclusions.*

FDA Label Image

Figure 6 (Cialis Uspi F006 V1)

This text is data from a medical study that reports changes in the International Prostate Symptom Score (IPSS) total score after treatment with either CIALIS 5mg or a placebo. The percentage change from the baseline is not specified in the text. The duration of treatment is shown on the x-axis of the graph shown, but the result is not available in the given text. The difference between the effects of CIALIS 5mg and the placebo is statistically significant (*p<0.01).*

FDA Label Image

Figure 7 (Cialis Uspi F007 V2)

FDA Label Image

Figure 8 (Cialis Uspi F008 V1)

The given text present the change from baseline in IPSS total score variable. There are two values mentioned, one for a medicine called CIAUS 5mg and the other for a placebo. The p-value for the difference between these two values is less than 0.01. The duration of treatment in both cases is 12 weeks.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.